 | • レポートコード：MRC2-11QY08973 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は組換えペプチドのグローバル市場について調査・分析したレポートです。種類別（グルカゴン、カルシトニン、その他）市場規模、用途別（腫瘍、造血系疾患、感染症、自己免疫疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別組換えペプチドの競争状況、市場シェア ・世界の組換えペプチド市場：種類別市場規模 2015年-2020年（グルカゴン、カルシトニン、その他） ・世界の組換えペプチド市場：種類別市場規模予測 2021年-2026年（グルカゴン、カルシトニン、その他） ・世界の組換えペプチド市場：用途別市場規模 2015年-2020年（腫瘍、造血系疾患、感染症、自己免疫疾患、その他） ・世界の組換えペプチド市場：用途別市場規模予測 2021年-2026年（腫瘍、造血系疾患、感染症、自己免疫疾患、その他） ・北米の組換えペプチド市場分析：米国、カナダ ・ヨーロッパの組換えペプチド市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの組換えペプチド市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の組換えペプチド市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの組換えペプチド市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sandoz Pharma、Stada Arzneimittel、Amgen、Hospira、Actavis、Cipla Ltd.、Wockhardt Ltd.、Biocon Ltd. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Recombinant Peptides Market
The global Recombinant Peptides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Recombinant Peptides Scope and Market Size
Recombinant Peptides market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Recombinant Peptides market is segmented into
Glucagon
Calcitonin
Other
Segment by Application, the Recombinant Peptides market is segmented into
Oncology
Blood Disorders
Infectious Diseases
Autoimmune Diseases
Other
Regional and Country-level Analysis
The Recombinant Peptides market is analysed and market size information is provided by regions (countries).
The key regions covered in the Recombinant Peptides market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Recombinant Peptides Market Share Analysis
Recombinant Peptides market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Recombinant Peptides business, the date to enter into the Recombinant Peptides market, Recombinant Peptides product introduction, recent developments, etc.
The major vendors covered:
Sandoz Pharma
Stada Arzneimittel
Amgen
Hospira
Actavis
Cipla Ltd.
Wockhardt Ltd.
Biocon Ltd.
1 Study Coverage
1.1 Recombinant Peptides Product Introduction
1.2 Market Segments
1.3 Key Recombinant Peptides Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Recombinant Peptides Market Size Growth Rate by Type
1.4.2 Glucagon
1.4.3 Calcitonin
1.4.4 Other
1.5 Market by Application
1.5.1 Global Recombinant Peptides Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Blood Disorders
1.5.4 Infectious Diseases
1.5.5 Autoimmune Diseases
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Recombinant Peptides Market Size, Estimates and Forecasts
2.1.1 Global Recombinant Peptides Revenue 2015-2026
2.1.2 Global Recombinant Peptides Sales 2015-2026
2.2 Global Recombinant Peptides, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Recombinant Peptides Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Recombinant Peptides Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Recombinant Peptides Competitor Landscape by Players
3.1 Recombinant Peptides Sales by Manufacturers
3.1.1 Recombinant Peptides Sales by Manufacturers (2015-2020)
3.1.2 Recombinant Peptides Sales Market Share by Manufacturers (2015-2020)
3.2 Recombinant Peptides Revenue by Manufacturers
3.2.1 Recombinant Peptides Revenue by Manufacturers (2015-2020)
3.2.2 Recombinant Peptides Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Recombinant Peptides Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Recombinant Peptides Revenue in 2019
3.2.5 Global Recombinant Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Recombinant Peptides Price by Manufacturers
3.4 Recombinant Peptides Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Peptides Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Peptides Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Peptides Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Recombinant Peptides Market Size by Type (2015-2020)
4.1.1 Global Recombinant Peptides Sales by Type (2015-2020)
4.1.2 Global Recombinant Peptides Revenue by Type (2015-2020)
4.1.3 Recombinant Peptides Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Recombinant Peptides Market Size Forecast by Type (2021-2026)
4.2.1 Global Recombinant Peptides Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Peptides Revenue Forecast by Type (2021-2026)
4.2.3 Recombinant Peptides Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Recombinant Peptides Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Recombinant Peptides Market Size by Application (2015-2020)
5.1.1 Global Recombinant Peptides Sales by Application (2015-2020)
5.1.2 Global Recombinant Peptides Revenue by Application (2015-2020)
5.1.3 Recombinant Peptides Price by Application (2015-2020)
5.2 Recombinant Peptides Market Size Forecast by Application (2021-2026)
5.2.1 Global Recombinant Peptides Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Peptides Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Peptides Price Forecast by Application (2021-2026)
6 North America
6.1 North America Recombinant Peptides by Country
6.1.1 North America Recombinant Peptides Sales by Country
6.1.2 North America Recombinant Peptides Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Recombinant Peptides Market Facts & Figures by Type
6.3 North America Recombinant Peptides Market Facts & Figures by Application
7 Europe
7.1 Europe Recombinant Peptides by Country
7.1.1 Europe Recombinant Peptides Sales by Country
7.1.2 Europe Recombinant Peptides Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Peptides Market Facts & Figures by Type
7.3 Europe Recombinant Peptides Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Recombinant Peptides by Region
8.1.1 Asia Pacific Recombinant Peptides Sales by Region
8.1.2 Asia Pacific Recombinant Peptides Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Recombinant Peptides Market Facts & Figures by Type
8.3 Asia Pacific Recombinant Peptides Market Facts & Figures by Application
9 Latin America
9.1 Latin America Recombinant Peptides by Country
9.1.1 Latin America Recombinant Peptides Sales by Country
9.1.2 Latin America Recombinant Peptides Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Recombinant Peptides Market Facts & Figures by Type
9.3 Central & South America Recombinant Peptides Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Peptides by Country
10.1.1 Middle East and Africa Recombinant Peptides Sales by Country
10.1.2 Middle East and Africa Recombinant Peptides Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Recombinant Peptides Market Facts & Figures by Type
10.3 Middle East and Africa Recombinant Peptides Market Facts & Figures by Application
11 Company Profiles
11.1 Sandoz Pharma
11.1.1 Sandoz Pharma Corporation Information
11.1.2 Sandoz Pharma Description and Business Overview
11.1.3 Sandoz Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sandoz Pharma Recombinant Peptides Products Offered
11.1.5 Sandoz Pharma Related Developments
11.2 Stada Arzneimittel
11.2.1 Stada Arzneimittel Corporation Information
11.2.2 Stada Arzneimittel Description and Business Overview
11.2.3 Stada Arzneimittel Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Stada Arzneimittel Recombinant Peptides Products Offered
11.2.5 Stada Arzneimittel Related Developments
11.3 Amgen
11.3.1 Amgen Corporation Information
11.3.2 Amgen Description and Business Overview
11.3.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Amgen Recombinant Peptides Products Offered
11.3.5 Amgen Related Developments
11.4 Hospira
11.4.1 Hospira Corporation Information
11.4.2 Hospira Description and Business Overview
11.4.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Hospira Recombinant Peptides Products Offered
11.4.5 Hospira Related Developments
11.5 Actavis
11.5.1 Actavis Corporation Information
11.5.2 Actavis Description and Business Overview
11.5.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Actavis Recombinant Peptides Products Offered
11.5.5 Actavis Related Developments
11.6 Cipla Ltd.
11.6.1 Cipla Ltd. Corporation Information
11.6.2 Cipla Ltd. Description and Business Overview
11.6.3 Cipla Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Cipla Ltd. Recombinant Peptides Products Offered
11.6.5 Cipla Ltd. Related Developments
11.7 Wockhardt Ltd.
11.7.1 Wockhardt Ltd. Corporation Information
11.7.2 Wockhardt Ltd. Description and Business Overview
11.7.3 Wockhardt Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Wockhardt Ltd. Recombinant Peptides Products Offered
11.7.5 Wockhardt Ltd. Related Developments
11.8 Biocon Ltd.
11.8.1 Biocon Ltd. Corporation Information
11.8.2 Biocon Ltd. Description and Business Overview
11.8.3 Biocon Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biocon Ltd. Recombinant Peptides Products Offered
11.8.5 Biocon Ltd. Related Developments
11.1 Sandoz Pharma
11.1.1 Sandoz Pharma Corporation Information
11.1.2 Sandoz Pharma Description and Business Overview
11.1.3 Sandoz Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sandoz Pharma Recombinant Peptides Products Offered
11.1.5 Sandoz Pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Recombinant Peptides Market Estimates and Projections by Region
12.1.1 Global Recombinant Peptides Sales Forecast by Regions 2021-2026
12.1.2 Global Recombinant Peptides Revenue Forecast by Regions 2021-2026
12.2 North America Recombinant Peptides Market Size Forecast (2021-2026)
12.2.1 North America: Recombinant Peptides Sales Forecast (2021-2026)
12.2.2 North America: Recombinant Peptides Revenue Forecast (2021-2026)
12.2.3 North America: Recombinant Peptides Market Size Forecast by Country (2021-2026)
12.3 Europe Recombinant Peptides Market Size Forecast (2021-2026)
12.3.1 Europe: Recombinant Peptides Sales Forecast (2021-2026)
12.3.2 Europe: Recombinant Peptides Revenue Forecast (2021-2026)
12.3.3 Europe: Recombinant Peptides Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Recombinant Peptides Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Recombinant Peptides Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Recombinant Peptides Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Recombinant Peptides Market Size Forecast by Region (2021-2026)
12.5 Latin America Recombinant Peptides Market Size Forecast (2021-2026)
12.5.1 Latin America: Recombinant Peptides Sales Forecast (2021-2026)
12.5.2 Latin America: Recombinant Peptides Revenue Forecast (2021-2026)
12.5.3 Latin America: Recombinant Peptides Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Recombinant Peptides Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Recombinant Peptides Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Recombinant Peptides Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Recombinant Peptides Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Recombinant Peptides Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Peptides Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Recombinant Peptides Market Segments
Table 2. Ranking of Global Top Recombinant Peptides Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Recombinant Peptides Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Glucagon
Table 5. Major Manufacturers of Calcitonin
Table 6. Major Manufacturers of Other
Table 7. Global Recombinant Peptides Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Recombinant Peptides Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Recombinant Peptides Sales by Regions 2015-2020 (K MT)
Table 10. Global Recombinant Peptides Sales Market Share by Regions (2015-2020)
Table 11. Global Recombinant Peptides Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Recombinant Peptides Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Recombinant Peptides Sales Share by Manufacturers (2015-2020)
Table 14. Global Recombinant Peptides Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Recombinant Peptides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Peptides as of 2019)
Table 16. Recombinant Peptides Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Recombinant Peptides Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Recombinant Peptides Price (2015-2020) (USD/MT)
Table 19. Recombinant Peptides Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Recombinant Peptides Product Type
Table 21. Date of International Manufacturers Enter into Recombinant Peptides Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Recombinant Peptides Sales by Type (2015-2020) (K MT)
Table 24. Global Recombinant Peptides Sales Share by Type (2015-2020)
Table 25. Global Recombinant Peptides Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Recombinant Peptides Revenue Share by Type (2015-2020)
Table 27. Recombinant Peptides Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Recombinant Peptides Sales by Application (2015-2020) (K MT)
Table 29. Global Recombinant Peptides Sales Share by Application (2015-2020)
Table 30. North America Recombinant Peptides Sales by Country (2015-2020) (K MT)
Table 31. North America Recombinant Peptides Sales Market Share by Country (2015-2020)
Table 32. North America Recombinant Peptides Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Recombinant Peptides Revenue Market Share by Country (2015-2020)
Table 34. North America Recombinant Peptides Sales by Type (2015-2020) (K MT)
Table 35. North America Recombinant Peptides Sales Market Share by Type (2015-2020)
Table 36. North America Recombinant Peptides Sales by Application (2015-2020) (K MT)
Table 37. North America Recombinant Peptides Sales Market Share by Application (2015-2020)
Table 38. Europe Recombinant Peptides Sales by Country (2015-2020) (K MT)
Table 39. Europe Recombinant Peptides Sales Market Share by Country (2015-2020)
Table 40. Europe Recombinant Peptides Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Recombinant Peptides Revenue Market Share by Country (2015-2020)
Table 42. Europe Recombinant Peptides Sales by Type (2015-2020) (K MT)
Table 43. Europe Recombinant Peptides Sales Market Share by Type (2015-2020)
Table 44. Europe Recombinant Peptides Sales by Application (2015-2020) (K MT)
Table 45. Europe Recombinant Peptides Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Recombinant Peptides Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Recombinant Peptides Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Recombinant Peptides Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Recombinant Peptides Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Recombinant Peptides Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Recombinant Peptides Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Recombinant Peptides Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Recombinant Peptides Sales Market Share by Application (2015-2020)
Table 54. Latin America Recombinant Peptides Sales by Country (2015-2020) (K MT)
Table 55. Latin America Recombinant Peptides Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Recombinant Peptides Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Recombinant Peptides Revenue Market Share by Country (2015-2020)
Table 58. Latin America Recombinant Peptides Sales by Type (2015-2020) (K MT)
Table 59. Latin America Recombinant Peptides Sales Market Share by Type (2015-2020)
Table 60. Latin America Recombinant Peptides Sales by Application (2015-2020) (K MT)
Table 61. Latin America Recombinant Peptides Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Recombinant Peptides Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Recombinant Peptides Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Recombinant Peptides Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Recombinant Peptides Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Recombinant Peptides Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Recombinant Peptides Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Recombinant Peptides Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Recombinant Peptides Sales Market Share by Application (2015-2020)
Table 70. Sandoz Pharma Corporation Information
Table 71. Sandoz Pharma Description and Major Businesses
Table 72. Sandoz Pharma Recombinant Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Sandoz Pharma Product
Table 74. Sandoz Pharma Recent Development
Table 75. Stada Arzneimittel Corporation Information
Table 76. Stada Arzneimittel Description and Major Businesses
Table 77. Stada Arzneimittel Recombinant Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Stada Arzneimittel Product
Table 79. Stada Arzneimittel Recent Development
Table 80. Amgen Corporation Information
Table 81. Amgen Description and Major Businesses
Table 82. Amgen Recombinant Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Amgen Product
Table 84. Amgen Recent Development
Table 85. Hospira Corporation Information
Table 86. Hospira Description and Major Businesses
Table 87. Hospira Recombinant Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Hospira Product
Table 89. Hospira Recent Development
Table 90. Actavis Corporation Information
Table 91. Actavis Description and Major Businesses
Table 92. Actavis Recombinant Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Actavis Product
Table 94. Actavis Recent Development
Table 95. Cipla Ltd. Corporation Information
Table 96. Cipla Ltd. Description and Major Businesses
Table 97. Cipla Ltd. Recombinant Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Cipla Ltd. Product
Table 99. Cipla Ltd. Recent Development
Table 100. Wockhardt Ltd. Corporation Information
Table 101. Wockhardt Ltd. Description and Major Businesses
Table 102. Wockhardt Ltd. Recombinant Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Wockhardt Ltd. Product
Table 104. Wockhardt Ltd. Recent Development
Table 105. Biocon Ltd. Corporation Information
Table 106. Biocon Ltd. Description and Major Businesses
Table 107. Biocon Ltd. Recombinant Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Biocon Ltd. Product
Table 109. Biocon Ltd. Recent Development
Table 110. Global Recombinant Peptides Sales Forecast by Regions (2021-2026) (K MT)
Table 111. Global Recombinant Peptides Sales Market Share Forecast by Regions (2021-2026)
Table 112. Global Recombinant Peptides Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 113. Global Recombinant Peptides Revenue Market Share Forecast by Regions (2021-2026)
Table 114. North America: Recombinant Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 115. North America: Recombinant Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Europe: Recombinant Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 117. Europe: Recombinant Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Asia Pacific: Recombinant Peptides Sales Forecast by Region (2021-2026) (K MT)
Table 119. Asia Pacific: Recombinant Peptides Revenue Forecast by Region (2021-2026) (US$ Million)
Table 120. Latin America: Recombinant Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 121. Latin America: Recombinant Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Middle East and Africa: Recombinant Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 123. Middle East and Africa: Recombinant Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Recombinant Peptides Players
Table 128. Recombinant Peptides Customers List
Table 129. Recombinant Peptides Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Peptides Product Picture
Figure 2. Global Recombinant Peptides Sales Market Share by Type in 2020 & 2026
Figure 3. Glucagon Product Picture
Figure 4. Calcitonin Product Picture
Figure 5. Other Product Picture
Figure 6. Global Recombinant Peptides Sales Market Share by Application in 2020 & 2026
Figure 7. Oncology
Figure 8. Blood Disorders
Figure 9. Infectious Diseases
Figure 10. Autoimmune Diseases
Figure 11. Other
Figure 12. Recombinant Peptides Report Years Considered
Figure 13. Global Recombinant Peptides Market Size 2015-2026 (US$ Million)
Figure 14. Global Recombinant Peptides Sales 2015-2026 (K MT)
Figure 15. Global Recombinant Peptides Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Recombinant Peptides Sales Market Share by Region (2015-2020)
Figure 17. Global Recombinant Peptides Sales Market Share by Region in 2019
Figure 18. Global Recombinant Peptides Revenue Market Share by Region (2015-2020)
Figure 19. Global Recombinant Peptides Revenue Market Share by Region in 2019
Figure 20. Global Recombinant Peptides Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Recombinant Peptides Revenue in 2019
Figure 22. Recombinant Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Recombinant Peptides Sales Market Share by Type (2015-2020)
Figure 24. Global Recombinant Peptides Sales Market Share by Type in 2019
Figure 25. Global Recombinant Peptides Revenue Market Share by Type (2015-2020)
Figure 26. Global Recombinant Peptides Revenue Market Share by Type in 2019
Figure 27. Global Recombinant Peptides Market Share by Price Range (2015-2020)
Figure 28. Global Recombinant Peptides Sales Market Share by Application (2015-2020)
Figure 29. Global Recombinant Peptides Sales Market Share by Application in 2019
Figure 30. Global Recombinant Peptides Revenue Market Share by Application (2015-2020)
Figure 31. Global Recombinant Peptides Revenue Market Share by Application in 2019
Figure 32. North America Recombinant Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Recombinant Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Recombinant Peptides Sales Market Share by Country in 2019
Figure 35. North America Recombinant Peptides Revenue Market Share by Country in 2019
Figure 36. U.S. Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Recombinant Peptides Market Share by Type in 2019
Figure 41. North America Recombinant Peptides Market Share by Application in 2019
Figure 42. Europe Recombinant Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Recombinant Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Recombinant Peptides Sales Market Share by Country in 2019
Figure 45. Europe Recombinant Peptides Revenue Market Share by Country in 2019
Figure 46. Germany Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Recombinant Peptides Market Share by Type in 2019
Figure 57. Europe Recombinant Peptides Market Share by Application in 2019
Figure 58. Asia Pacific Recombinant Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Recombinant Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Recombinant Peptides Sales Market Share by Region in 2019
Figure 61. Asia Pacific Recombinant Peptides Revenue Market Share by Region in 2019
Figure 62. China Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Recombinant Peptides Market Share by Type in 2019
Figure 85. Asia Pacific Recombinant Peptides Market Share by Application in 2019
Figure 86. Latin America Recombinant Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Recombinant Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Recombinant Peptides Sales Market Share by Country in 2019
Figure 89. Latin America Recombinant Peptides Revenue Market Share by Country in 2019
Figure 90. Mexico Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Recombinant Peptides Market Share by Type in 2019
Figure 97. Latin America Recombinant Peptides Market Share by Application in 2019
Figure 98. Middle East and Africa Recombinant Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Recombinant Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Recombinant Peptides Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Recombinant Peptides Revenue Market Share by Country in 2019
Figure 102. Turkey Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Recombinant Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Recombinant Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Recombinant Peptides Market Share by Type in 2019
Figure 109. Middle East and Africa Recombinant Peptides Market Share by Application in 2019
Figure 110. North America Recombinant Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. North America Recombinant Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Recombinant Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Europe Recombinant Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Recombinant Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Asia Pacific Recombinant Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Recombinant Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Latin America Recombinant Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Recombinant Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Middle East and Africa Recombinant Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
抗炎症ペプチドの世界市場（～2026年） Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal's skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and…- 経口タンパク質・ペプチドの世界市場（～2026年） Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and protein-based drugs. The oral protein and peptide-based therapeutics market for diabetes is expected to gro…
- 治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
- ペプチドの世界市場（～2026年） Market Analysis and Insights: Global Peptides Market The global Peptides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Peptides Scope and Market Size Peptides market is segmented by Type, and by Application. Players,…
- 組換えヒトアルブミンの世界市場（～2026年） Recombinant human albumin (rHA) is a highly purified animal-, virus-, and prion-free product developed as an alternative to human serum albumin (HSA), to which it is structurally equivalent. Market Analysis and Insights: Global Recombinant Human Albumin Market The global Recombinant Human Albumin ma…